日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors

人类白细胞抗原-G (HLA-G) x CD3 双特异性抗体 JNJ-78306358 用于治疗晚期实体肿瘤的安全性和临床活性

期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-024-03790-7
Ravit Geva, Maria Vieito, Jorge Ramon, Ruth Perets, Manuel Pedregal, Elena Corral, Bernard Doger, Emiliano Calvo, Jorge Bardina, Elena Garralda, Regina J Brown, James G Greger, Shujian Wu, Douglas Steinbach, Tsun-Wen Sheena Yao, Yu Cao, Josh Lauring, Ruchi Chaudhary, Jaymala Patel, Bharvin Patel, Vi
肿瘤
其它细胞
Human
发表日期：2024
文献求助 收藏

Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study

改良柑橘果胶治疗非转移性生化复发性前列腺癌：前瞻性 II 期研究的长期结果

期刊:Nutrients
影响因子:4.8
doi:10.3390/nu15163533
Daniel Keizman, Moshe Frenkel, Avivit Peer, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, Ido Wolf, Ravit Geva, David Margel, Keren Rouvinov, Anat Stern, Hadas Dresler, Igal Kushnir, Isaac Eliaz
肿瘤
前列腺癌
发表日期：2023
文献求助 收藏

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

针对晚期难治性实体瘤患者的靶向PD-L1和4-1BB的双特异性抗体（GEN1046）的临床前特征和I期试验结果

期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-21-1345
Alexander Muik，Elena Garralda，Isil Altintas，Friederike Gieseke，Ravit Geva，Eytan Ben-Ami，Corinne Maurice-Dror，Emiliano Calvo，Patricia M LoRusso，Guzman Alonso，Maria E Rodriguez-Ruiz，Kristina B Schoedel，Jordan M Blum，Bianca Sänger，Theodora W Salcedo，Saskia M Burm，Eliana Stanganello，Dennis Verzijl，Fulvia Vascotto，Angelica Sette，Juliane Quinkhardt，Theo S Plantinga，Aras Toker，Edward N van den Brink，Mark Fereshteh，Mustafa Diken，David Satijn，Sebastian Kreiter，Esther C W Breij，Gaurav Bajaj，Eleni Lagkadinou，Kate Sasser，Özlem Türeci，Ulf Forssmann，Tahamtan Ahmadi，Uğur Şahin #，Maria Jure-Kunkel #，Ignacio Melero #
PD-L1
发表日期：2022
文献求助 收藏

Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study

改良柑橘果胶治疗非转移性生化复发性前列腺癌：前瞻性 II 期研究结果

期刊:Nutrients
影响因子:4.8
doi:10.3390/nu13124295
Daniel Keizman, Moshe Frenkel, Avivit Peer, Igal Kushnir, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, David Margel, Ido Wolf, Ravit Geva, Hadas Dresler, Keren Rouvinov, Noa Rapoport, Isaac Eliaz0
肿瘤
前列腺癌
发表日期：2021
文献求助 收藏